Portraits of MS
We’re happy to introduce to you some of the nice folks from the Shared Solutions® community.

Cindy W.
On COPAXONE® for RRMS since 2001
Married, two children
About Me

Eileen K.
On COPAXONE® for RRMS since 1998
Married, two children
About Me

Heath C.
On COPAXONE® for RRMS since 1998
Married, three children
About Me

Joan A.
On COPAXONE® for RRMS since 2003
Married, two children
About Me

Kathy S.
On COPAXONE® for RRMS since 2002
Married, one child
About Me

Kurt L.
On COPAXONE® for RRMS since 1998
Married, three children
About Me

Leslie T.
On COPAXONE® for RRMS since 1998
Busy mom of two children
About Me

Michelle T.
On COPAXONE® for RRMS since 2002
Married, two children
About Me

Mike W.
On COPAXONE® for RRMS since 2005
Married
About Me

Phyllis J.
On COPAXONE® for RRMS since 2003
Married, two children
About Me

Rob F.
On COPAXONE® for RRMS since 2002
Married, two children
About Me

Stella S.
On COPAXONE® for RRMS since 1998
Mom of two children
About Me

Terry H.
On COPAXONE® for RRMS since 2002
Married, three children
About Me
- COPAXONE® (glatiramer acetate injection) is indicated for the reduction of the frequency of relapses in relapsing-remitting multiple sclerosis, including patients who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis.
Important Safety Information About COPAXONE®
- The most common side effects of COPAXONE® are redness, pain, swelling, itching, or a lump at the site of injection, flushing, rash, shortness of breath, and chest pain. These reactions are usually mild and seldom require professional treatment. Be sure to tell your doctor about any side effects.
Some patients report a short-term reaction right after injecting COPAXONE®. This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain with heart palpitations, anxiety, and trouble breathing. These symptoms generally appear within minutes of an injection, last about 15 minutes, and go away by themselves without further problems.
A permanent indentation under the skin at the injection site may occur, due to a local destruction of fat tissue. Be sure to follow proper injection technique and inform your doctor of any skin changes.
After you inject COPAXONE®, call your doctor right away if you develop hives, skin rash with irritation, dizziness, sweating, chest pain, trouble breathing, severe pain at the injection site or other uncomfortable changes in your general health. Do not give yourself any more injections until your doctor tells you to begin again.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Suggested articles
Benefits & Insurance Assistance
COPAXONE Co-pay Solutions™
Therapy and Immune Health
10 Tips for CarePartners
Choosing a Therapy
Your MS Online Planner
My recent articles
Your Immune System
Team COPAXONE®
Insurance FAQs
About COPAXONE®
*IMS Health National Prescription Audit, May 2011. Data is proprietary to IMS Health.
COPAXONE® is a registered trademark of Teva Pharmaceutical Industries Ltd. Shared Solutions® is a registered trademark of Teva Neuroscience, Inc. autoject® 2 for glass syringe is a registered trademark of Owen Mumford, Ltd. COPAXONE CO-PAY SOLUTIONS™ is a trademark of Teva Pharmaceutical Industries Ltd. © 2011, Teva Neuroscience, Inc. All Rights Reserved. This site is intended for US residents only.
The brands listed are the trademarks and registered trademarks of their respective owners.